11,945 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by Twin Securities Inc.

Twin Securities Inc. bought a new stake in Amedisys, Inc. (NASDAQ:AMED) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 11,945 shares of the health services provider’s stock, valued at approximately $1,153,000. Amedisys comprises about 1.3% of Twin Securities Inc.’s holdings, making the stock its 10th biggest position.

Other institutional investors also recently added to or reduced their stakes in the company. Alpine Associates Management Inc. increased its holdings in shares of Amedisys by 0.9% during the 2nd quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock worth $117,586,000 after purchasing an additional 11,000 shares during the period. Dimensional Fund Advisors LP increased its stake in Amedisys by 4.0% during the second quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after acquiring an additional 19,660 shares during the period. Calamos Advisors LLC increased its stake in Amedisys by 11.6% during the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after acquiring an additional 41,220 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Amedisys by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after acquiring an additional 9,004 shares in the last quarter. Finally, Highbridge Capital Management LLC lifted its position in shares of Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after acquiring an additional 83,200 shares during the period. 94.36% of the stock is owned by institutional investors.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $91.41 on Friday. The business’s 50 day moving average is $94.86 and its 200-day moving average is $95.64. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $2.99 billion, a PE ratio of 36.27, a PEG ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a 1-year low of $88.81 and a 1-year high of $98.95.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the prior year, the firm earned $0.98 EPS. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. Sell-side analysts predict that Amedisys, Inc. will post 4.55 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.